Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery-Reference-Cited by-同舟云学术

Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery

Published:2013-04-17 Issue:4 Volume:8 Page:e61578
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bathen Tone F.,Geurts Brigitte,Sitter Beathe,Fjøsne Hans E.,Lundgren Steinar,Buydens Lutgarde M.,Gribbestad Ingrid S.,Postma Geert,Giskeødegård Guro F.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Cancer incidence in the United Kingdom: projections to the year 2030;M Mistry;Br J Cancer,2011

2. (2011) Cancer in Norway 2009 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway.

3. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors;J Atkins;J Surg Res,2012

4. The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer;PJ Lovrics;Am J Surg,2009

5. Metabolomics–the link between genotypes and phenotypes;O Fiehn;Plant Mol Biol,2002

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipidomics and metabolomics as potential biomarkers for breast cancer progression;npj Metabolic Health and Disease;2024-09-02

2. Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes;Oncogenesis;2024-06-13

3. In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla;International Journal of Molecular Sciences;2024-01-31

4. The Role of Amino Acids in the Diagnosis, Risk Assessment, and Treatment of Breast Cancer: A Review;Current Issues in Molecular Biology;2023-09-13

5. Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer;Cancers;2023-09-01